Docusign Inc. (NASDAQ:DOCU – Get Free Report) shares hit a new 52-week low during trading on Monday . The stock traded as low as $40.42 and last traded at $41.0490, with a volume of 796264 shares traded. The stock had previously closed at $44.48.
Docusign News Summary
Here are the key news stories impacting Docusign this week:
- Positive Sentiment: DocuSign announced its Intelligent Agreement Management (IAM) platform is now available inside Anthropic’s Cowork, letting customers create, review and execute contract workflows via natural‑language prompts — a strategic AI integration that could expand enterprise usage and strengthen DOCU’s AI positioning. Docusign Partners with Anthropic
- Positive Sentiment: Broader relief rally in software stocks after Anthropic’s partnership announcements lifted peers and helped provide a sentiment tailwind for DOCU — investors rotated back into AI-play names that show clear integrations with leading AI platforms. US software stocks climb as Anthropic announcement sparks relief rally
- Neutral Sentiment: DocuSign set its fiscal Q4 2026 results release and conference call for Mar. 17 (after market close) — a near‑term catalyst that could drive volatility depending on revenue/AI adoption commentary. Docusign Announces Timing of Fourth Quarter Fiscal 2026 Earnings Conference Call
- Neutral Sentiment: Zacks flagged DOCU as a heavily watched name, which can increase short-term volume and attention but doesn’t change fundamentals by itself. Docusign Inc. (DOCU) is Attracting Investor Attention
- Negative Sentiment: Jefferies and other firms have recently reset software coverage and downgraded DocuSign, weighing on sentiment and contributing to recent share weakness. Analyst downgrades raise the risk of further near-term selling pressure. Jefferies resets software ratings, downgrades 4 stocks
- Negative Sentiment: DOCU has hit multi‑month/52‑week lows amid concerns about product concentration, limited defensible data moats versus large AI platforms, and high multiples — risks highlighted in recent industry commentary that could cap upside until fundamentals or positioning improve. Docusign stock hits 52-week low
Wall Street Analyst Weigh In
A number of research firms have recently issued reports on DOCU. Weiss Ratings reaffirmed a “hold (c)” rating on shares of Docusign in a report on Wednesday, January 21st. Bank of America dropped their price objective on shares of Docusign from $102.00 to $82.00 and set a “neutral” rating for the company in a research note on Friday, December 5th. Wedbush decreased their target price on shares of Docusign from $85.00 to $75.00 and set a “neutral” rating on the stock in a research note on Friday, December 5th. UBS Group lowered their target price on Docusign from $85.00 to $75.00 and set a “neutral” rating on the stock in a report on Friday, December 5th. Finally, Zacks Research cut Docusign from a “strong-buy” rating to a “hold” rating in a report on Monday, November 24th. Five analysts have rated the stock with a Buy rating and sixteen have given a Hold rating to the company’s stock. Based on data from MarketBeat.com, the stock currently has an average rating of “Hold” and an average target price of $78.80.
Docusign Stock Up 1.0%
The stock has a 50-day simple moving average of $57.54 and a 200 day simple moving average of $67.10. The company has a market cap of $8.66 billion, a PE ratio of 30.25, a P/E/G ratio of 1.83 and a beta of 1.00.
Insider Transactions at Docusign
In other news, insider James P. Shaughnessy sold 12,000 shares of the business’s stock in a transaction that occurred on Friday, January 2nd. The shares were sold at an average price of $67.03, for a total value of $804,360.00. Following the sale, the insider directly owned 54,550 shares of the company’s stock, valued at approximately $3,656,486.50. The trade was a 18.03% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, CEO Allan C. Thygesen sold 26,250 shares of the company’s stock in a transaction that occurred on Friday, January 9th. The stock was sold at an average price of $69.60, for a total transaction of $1,827,000.00. Following the completion of the transaction, the chief executive officer owned 142,261 shares in the company, valued at approximately $9,901,365.60. This represents a 15.58% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Insiders sold 78,292 shares of company stock worth $5,374,260 in the last 90 days. Insiders own 1.66% of the company’s stock.
Institutional Inflows and Outflows
A number of large investors have recently added to or reduced their stakes in DOCU. Central Pacific Bank Trust Division acquired a new stake in shares of Docusign in the fourth quarter valued at $25,000. Modus Advisors LLC acquired a new position in Docusign during the 4th quarter worth about $27,000. Torren Management LLC purchased a new position in Docusign during the 4th quarter valued at about $28,000. Aventura Private Wealth LLC acquired a new position in Docusign in the 4th quarter valued at about $30,000. Finally, True Wealth Design LLC grew its position in Docusign by 105.2% in the 4th quarter. True Wealth Design LLC now owns 433 shares of the company’s stock valued at $30,000 after acquiring an additional 222 shares in the last quarter. 77.64% of the stock is currently owned by institutional investors and hedge funds.
About Docusign
DocuSign, Inc (NASDAQ: DOCU) is a leading provider of electronic signature and digital transaction management solutions. The company’s flagship offering, DocuSign eSignature, enables organizations to send, sign and manage legally binding electronic agreements securely in the cloud. Beyond eSignature, DocuSign’s Agreement Cloud combines contract lifecycle management, document generation, and workflow automation to streamline agreement processes from initiation through execution and storage.
DocuSign’s platform serves a diverse customer base spanning industries such as finance, real estate, healthcare, technology, and government.
Further Reading
- Five stocks we like better than Docusign
- The gold chart Wall Street is terrified of…
- America’s 1776 happening again
- This makes me furious
- Buy this Gold Stock Before May 2026
- What a Former CIA Agent Knows About the Coming Collapse
Receive News & Ratings for Docusign Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Docusign and related companies with MarketBeat.com's FREE daily email newsletter.
